What's Happening?
Paris-based One Biosciences, a startup backed by Institut Curie, is establishing its first U.S. location in Albany, New York. The company plans to set up a high-complexity lab and computational analytics operation, supported by up to $525,000 in performance-based
tax credits from Empire State Development. This expansion is expected to create 42 life science jobs and involve $18 million in investments over the next five years. One Biosciences aims to leverage its proprietary technology to address clinical and scientific needs in tumor ecosystem characterization through single-cell profiling. The company is excited to collaborate with local researchers and physicians in Albany's life sciences ecosystem.
Why It's Important?
The establishment of One Biosciences in Albany signifies a boost to the local economy and the life sciences sector. By creating new jobs and investing in advanced research facilities, the company contributes to the region's economic development. The focus on single-cell profiling technology highlights the growing importance of personalized medicine in cancer treatment, potentially leading to more effective therapies. This move also aligns with New York State's efforts to attract cutting-edge companies and foster medical breakthroughs, enhancing its reputation as a hub for life sciences innovation.
What's Next?
One Biosciences will begin staffing and equipping its Albany facility, with operations expected to ramp up over the coming years. The company will likely engage in partnerships with local academic and research institutions to further its research goals. As the facility becomes operational, it may attract additional biotech companies to the region, fostering a collaborative environment for innovation. The success of this expansion could lead to further investments and job creation in the life sciences sector across New York State.
